- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04427631
Exploring Interventions for Glue Ear During Covid-19 (BIG-C)
Exploring Interventions for Children With Chronic Otitis Media With Effusion ('Glue Ear') When Services Are Reduced During Covid-19
Study Overview
Status
Intervention / Treatment
Detailed Description
Hypothesis
Transmission of speech aided by a wireless bone-conduction headphone connected to a wireless Bluetooth microphone during the prolonged waiting time (during the coronavirus pandemic) for the insertion of grommets, as well as access to the Hear Glue Ear software application is an acceptable management strategy during the coronavirus period where other forms of treatment and support are not available or indefinitely delayed. Questionnaires intend to capture data regarding families perception of child quality of life and developmental outcomes with this intervention.
Aim To quantify the differences in speech, language, and quality of life outcome measures between a group of children aided with a bone-conduction headphone and Hearing Glue Ear app during the coronavirus pandemic where usual care has been delayed such as waiting for grommet insertion.
Participants A total of 20 children will be enrolled in the study. If drop outs occur, new participants will be invited to replace those who withdrew from the study.
Participant recruitment Children known to Cambridge Audiology Services and known to have a diagnosis of glue ear will be invited to take part in the study if they satisfy the inclusion criteria. Consent will be obtained from their parents and an age appropriate explanation given to the child with the chance for the child to sign an age- appropriate assent form.
Design The free Hear glue Ear software application will be referred to as 'the app' in this section.
A single arm design will be used. Participants will have a glue ear (Otitis Media with Effusion, OME) diagnosis made in the National Health Service Cambridge Audiology clinics. They will be given information and invited to take part in the study at a time convenient to them.
Participants in the Study will be sent the bone conduction headphones, microphone and details of how to download the free Hear Glue Ear app. A member of the research team will arrange a telephone/ video consultation to aid set up and use of the product set.
The parent/ carer will be asked to fill out a questionnaire about their child's listening, language and quality of life before and after using the product set.
The bone conduction headphones used in this study are currently on the market as a headphones used by people practising outdoor sports. It is a type of headphones designed for children and adults to listen to music and speech via bluetooth to a phone or device. It is not a medical device but has a Conformity marking of Europe (known as CE mark) for being used as a set of headphones for any member of the public.
Follow-up will be carried out after 3 months unless the family request more frequent support. A member of the research team will email or telephone or video- consult (depending on the preference of the family) after 3 months to see if the family used the Hear Glue Ear headphones and/ or app at home and gather feedback. Parents will be asked to complete questionnaires again at this point.
The patient's family 'general practitioner' doctor will be informed (with parental consent) if the child is involved in the research study. The child's inclusion in the research study should not affect or alter any usual medical care.
Follow up will also be possible when the child attends their next NHS hearing test appointment when services reopen after or during the coronavirus pandemic.
Timing of the study and practical aspects
Invitation to take part
The children and their families will be given a pack containing:
- Parent and child study information sheets. The family and the child will have the chance to ask initial questions about the study within the remote telephone/ video clinic appointment.
- Consent form, which the family can be encouraged to complete and return by email.
Quality of life questionnaire for children with Otitis Media known as OMQ14 Speech, language and listening questionnaire.
Website address: http://hearglueear.wordpress.com (study details including copies of consent forms and questionnaires will be available on the website) and contact email:
hearglueear@outlook.com (for the families to direct any queries).
Once the child has been recruited
- The children and their family will be sent a bone conduction headphone, microphone and information on how to download the free Hear Glue Ear app.
- Participant's personal and contact details, as well as a copy of their last audiology results will be assigned a code that will be used for data collection, and their personal data and contact details will be kept separately.
- Participating families will have a remote telephone/ video appointment offered at the beginning of the study and 3 months after their involvement.
- Three months after their first appointment All the children will be automatically followed up with another telephone/ video consultation.
The family will be encouraged to fill out the final questionnaires, which are the same validated questionnaires used at the beginning of the study (before the intervention) as well as a non- validated acceptability questionnaire.
A website with videos, support information, instructions, and useful materials was created for use of the participants: http://hearglueear.wordpress.com
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tamsin M Holland Brown, MBBS MRCPCH
- Phone Number: 07977160976
- Email: drtamsinhollandbrown@gmail.com
Study Contact Backup
- Name: alison Sansome, MBBS MRCPCH
- Phone Number: 01223218072
- Email: alison.sansome@nhs.net
Study Locations
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, United Kingdom, CB1 3DF
- Peacock Children's centre. Brookfields Hospital
-
Contact:
- Tamsin M Holland Brown, MBBS MRCPCH
- Phone Number: 07977160976
- Email: drtamsinhollandbrown@gmail.com
-
Contact:
- Alison Sansome, BM BCh MA MRCPCH
- Phone Number: 01223218072
- Email: alison.sansome@nhs.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 3-11y
- English used as a main language (since app is only written in English)
- Glue ear with a hearing loss affecting at least 2 frequencies in at least one ear
Exclusion Criteria:
- age range outside the 3-11 y parameter
- normal hearing
- not using english as a main language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single arm study
The family will complete questionnaires before and after each childs intervention.
Therefore each child will act as their own control.
|
Children will be offered hearing support with bone conduction headphones that can either be paired to a microphone or to a tablet/ phone/ computer to help children to hear.
The Hear Glue Ear app is available for free to provide speech and language enrichment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
acceptability of management strategy, questionnaire
Time Frame: Acceptability will be measured on a Likert scale pre-assessment and the end of 3 months of using the intervention
|
questionnaire based accpetability question.
A higher acceptability score will be positive for the intervention.
|
Acceptability will be measured on a Likert scale pre-assessment and the end of 3 months of using the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
quality of life questionnaire OMQ-14
Time Frame: Questionnaires at beginning of study (as a baseline assessment and after 3 months of using the intervention. The sc
|
validated questionnaire assessing quality of life in children with glue ear.
The questionnaire assess disease- related hearing difficulty and treatment-related improvements in hearing.
Improved (lower) scores will indicate a more positive response from the intervention.
|
Questionnaires at beginning of study (as a baseline assessment and after 3 months of using the intervention. The sc
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 262816
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Conductive
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalSahlgrenska University Hospital, SwedenCompletedConductive Hearing Loss | Mixed Hearing LossSweden
-
Audioptics Medical IncorporatedNot yet recruitingConductive Hearing Loss, Middle Ear
-
Oticon MedicalActive, not recruitingConductive Hearing Loss | Mixed Hearing LossSweden
-
Oticon MedicalCompletedConductive Hearing Loss | Mixed Hearing Loss | Unilateral Partial DeafnessSweden
-
Oticon MedicalCompletedConductive Hearing Loss | Unilateral Partial Deafness | Mixed Conductive-sensorineural Hearing LossNetherlands
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossUnited States, Netherlands, Australia, Germany, Poland
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossAustralia
-
Khon Kaen UniversityPrince of Songkla University; Chiang Mai UniversityNot yet recruitingNormal Hearing | Conductive Hearing Loss, Middle EarThailand
Clinical Trials on Bone conduction headphones
-
Children's HealthActive, not recruitingAutism Spectrum DisorderUnited States
-
Children's Hearing Evaluation and Amplification...UnknownAuditory Processing DisorderUnited Kingdom
-
University Hospital Inselspital, BerneCompletedHearing Loss, ConductiveSwitzerland
-
Medical University of ViennaRecruiting
-
Region StockholmRecruiting
-
Zydolab - Institute of Cytology and Immune CytochemistryCompleted
-
University of MiamiMed-El CorporationTerminated
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
Med-El CorporationRecruitingHearing Loss, Conductive | Hearing Loss, MixedUnited States
-
Oticon MedicalActive, not recruitingHearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedGermany, Netherlands, United Kingdom